Soluble receptors for advanced glycation endproducts are predictors of insulin sensitivity and affected by weight loss.

Nutr Diabetes

Nutrition, Eumetabolism and Health Group, Institut d'Investigació Biomèdica de Girona (IDIBGI-CERCA), Av. França 30, 17007, Girona, Spain.

Published: October 2024

Background: Mice experiments have underscored the efficacy of pharmacological inhibition of advanced glycation endproducts (AGEs) through the use of soluble receptors for advanced glycation endproducts (sRAGE) in mitigating obesity-linked metabolic disruptions and insulin resistance. However, human studies have presented conflicting findings regarding the correlation between circulating sRAGE levels and insulin resistance, as well as glucose tolerance. Here, we aimed to delve deeper into the relationship between sRAGE levels and systemic insulin sensitivity.

Methods: Plasma sRAGE levels, hyperinsulinemic-euglycemic clamp, and continuous glucose monitoring were measured in two independent cross-sectional case-control studies [cohort 1 (n = 180) and cohort 2 (n = 124)]. In addition, a subgroup of 42 participants with obesity were followed for 12 months. In 14 of these participants, weight loss was achieved through bariatric surgery intervention.

Results: Our results revealed a significant association between plasma sRAGE levels and both insulin sensitivity and glycemic control parameters, even after adjustments for age, sex, and BMI. Furthermore, longitudinal analysis demonstrated that interventions aimed at weight loss led to reductions in fasting glucose and HbA1c levels, concurrently with increases in sRAGE levels.

Conclusions: These findings underscore that sRAGE levels were strongly associated with insulin sensitivity and glycemic control, suggesting a possible role of sRAGE in preserving insulin sensitivity and maintaining glycemic control, which should be confirmed in further studies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11489772PMC
http://dx.doi.org/10.1038/s41387-024-00345-8DOI Listing

Publication Analysis

Top Keywords

srage levels
20
insulin sensitivity
16
advanced glycation
12
glycation endproducts
12
weight loss
12
glycemic control
12
soluble receptors
8
receptors advanced
8
srage
8
insulin resistance
8

Similar Publications

Background: Although dyslipidemia has been acknowledged as a risk factor for Alzheimer's disease (AD), the effects of lipid-lowering drugs on AD have not been determined. The primary pathophysiological hallmark of AD is the deposition of amyloid-β (Aβ) plaques in the brain. Plasma Aβ levels are influenced by the transport of Aβ from the central nervous system to the peripheral blood.

View Article and Find Full Text PDF

Are the Soluble Receptors sRAGE, sRANKL, and Osteoprotegerin Associated with Anemia in Rheumatoid Arthritis?

Int J Mol Sci

November 2024

Department of Medical Biochemistry, Faculty of Pharmacy, Medical University of Plovdiv, 15A Vasil Aprilov Blvd., 4002 Plovdiv, Bulgaria.

Article Synopsis
  • Rheumatoid arthritis (RA) is an autoimmune disease that can cause inflammation and lead to anemia, and this study explores how certain soluble receptors are affected in different RA patient subgroups based on anemia types and iron levels.
  • The findings show higher levels of sRAGE and sRANKL in patients with anemia of chronic disease combined with iron deficiency anemia (ACD/IDA), while OPG levels decreased, indicating potential differences in disease effects between anemia types.
  • The study concludes that soluble receptors like sRAGE, sRANKL, and OPG could serve as biomarkers in RA patients, helping to identify those at risk for anemia and better understand the condition's progression.
View Article and Find Full Text PDF

Background: Advanced glycation end products (AGE) and their receptors (RAGE) have been implicated in developing periodontal complications in diabetic patients. This study aimed to identify salivary AGE, RAGE, soluble RAGE (sRAGE), and active-matrix metalloproteinase-8 (aMMP-8) levels at varying glycemic levels in periodontitis patients.

Methods: Ninety-eight participants were categorized into uncontrolled DM-PD group (n = 27)-periodontitis patients with uncontrolled Type 2 diabetes mellitus (T2DM) (glycated hemoglobin [HbA1c] ≥7%); controlled DM-PD group (n = 33)-periodontitis patients with controlled T2DM (HbA1c 5.

View Article and Find Full Text PDF
Article Synopsis
  • - The study examines how lung function, inflammatory responses, and cytokines change in a mouse model of chronic obstructive pulmonary disease (COPD) caused by cigarette smoke exposure, focusing on the role of sRAGE.
  • - Healthy male C57BL/6J mice were divided into a Smoke-Exposed group and a Control group; lung function and inflammation markers were measured at various time points up to 120 days.
  • - Results showed significant lung function decline and increased inflammation in smoke-exposed mice, with high sRAGE levels in the early days that decreased as COPD developed, indicating its potential role in the disease progression.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how COVID-19 affects bone turnover and remodeling, an area not thoroughly examined until now, especially focusing on elderly patients facing orthopedic surgery.
  • Researchers evaluated osteoimmunological biomarkers, particularly the RANKL/OPG ratio, to assess bone resorption and fragility in COVID-19-positive patients, finding significant correlations with other inflammatory markers.
  • Findings suggest that using RANKL/OPG as a biomarker can enhance the clinical understanding of COVID-19's impact on bone health, particularly important for aging patients with higher risks of bone fragility during surgery.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!